Perspective Therapeutics Inc (CATX)
3.47
+0.47
(+15.67%)
USD |
NYAM |
Nov 22, 16:00
3.49
+0.02
(+0.58%)
Pre-Market: 20:00
Perspective Therapeutics Cash from Investing (Quarterly): -29.74M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -29.74M |
| June 30, 2024 | -3.295M |
| March 31, 2024 | -47.30M |
| December 31, 2023 | -0.089M |
| September 30, 2023 | -0.227M |
| June 30, 2023 | -0.573M |
| March 31, 2023 | 25.26M |
| September 30, 2022 | -35.17M |
| June 30, 2022 | -0.123M |
| March 31, 2022 | -0.026M |
| December 31, 2021 | -0.081M |
| September 30, 2021 | -0.054M |
| June 30, 2021 | -0.138M |
| March 31, 2021 | -0.099M |
| December 31, 2020 | -0.06M |
| September 30, 2020 | -0.113M |
| June 30, 2020 | -0.039M |
| March 31, 2020 | -0.044M |
| December 31, 2019 | -0.106M |
| September 30, 2019 | -0.098M |
| June 30, 2019 | 2.239M |
| March 31, 2019 | 2.205M |
| December 31, 2018 | 2.246M |
| September 30, 2018 | -6.289M |
| June 30, 2018 | 1.201M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.494M |
| December 31, 2017 | 0.479M |
| September 30, 2017 | -0.315M |
| June 30, 2017 | 2.045M |
| March 31, 2017 | -0.083M |
| December 31, 2016 | -0.121M |
| September 30, 2016 | -0.327M |
| June 30, 2016 | 5.653M |
| March 31, 2016 | 5.768M |
| December 31, 2015 | -0.087M |
| September 30, 2015 | -2.577M |
| June 30, 2015 | 4.700M |
| March 31, 2015 | 0.8751M |
| December 31, 2014 | -0.1134M |
| September 30, 2014 | -4.677M |
| June 30, 2014 | -15.42M |
| March 31, 2014 | -0.0055M |
| December 31, 2013 | -0.0114M |
| September 30, 2013 | -0.0046M |
| June 30, 2013 | 0.0002M |
| March 31, 2013 | 0.0005M |
| December 31, 2012 | -0.0066M |
| September 30, 2012 | -0.0069M |
| June 30, 2012 | -0.0264M |
| March 31, 2012 | -0.0414M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-47.30M
Minimum
Mar 2024
25.26M
Maximum
Mar 2023
-4.842M
Average
-0.106M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics Inc | -0.009M |
| Retractable Technologies Inc | 2.926M |
| InfuSystems Holdings Inc | -2.856M |
| Xtant Medical Holdings Inc | -2.009M |
| Catheter Precision Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.366M |
| Cash from Financing (Quarterly) | 0.628M |
| Free Cash Flow | -40.58M |
| Free Cash Flow Per Share (Quarterly) | -0.373 |
| Free Cash Flow Yield | -21.77% |